Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen. (2017)
Attributed to:
The University of Manchester (UoM) bid for phase III of MRC Confidence in Concept funding
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cam4.967
PubMed Identifier: 28109061
Publication URI: http://europepmc.org/abstract/MED/28109061
Type: Journal Article/Review
Volume: 6
Parent Publication: Cancer medicine
Issue: 2
ISSN: 2045-7634